A welcome initiative but...
This is a welcome initiative but probably defective.
For practical purposes it is essential not so much that the drug
companies themselves publish the information as that the sponsored
organisations publish it: otherwise you are still left trying to guess
which drug companies are sponsoring them, if any.
I also have no doubt that the companies themselves will maintain that
they are in some way in technical compliance with this recommendation, but
a scoot round the websites of several high profile pharmaceutical
companies is presently not very revealing.
It might become helpful if an easily accessible central register was
set up, as a point of reference.
Competing interests: No competing interests